Skip to content

Clinical trials

Completed Genetic Diseases, Inborn trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Completed Country / region: South Africa Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20141
20171
20182
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company2
Kastle Therapeutics, LLC2
Regeneron Pharmaceuticals2
BioMarin Pharmaceutical1
NewAmsterdam Pharma1
University of KwaZulu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn9
Metabolic Diseases5
Metabolism, Inborn Errors4
Blood Coagulation Disorders3
Blood Coagulation Disorders, Inherited3
Coagulation Protein Disorders3
Dyslipidemias3
Hematologic Diseases3
Hemophilia A3
Hemorrhagic Disorders3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.